RegulyzeKatphala
Myrica cerifera/nagi · Bark extract
Katphala (Myrica cerifera/nagi) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | As specified / GMP | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Katphala
Katphala is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Myrica cerifera/nagi). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Katphala permitted in nutraceuticals under FSSAI (India)?
Katphala (Myrica cerifera/nagi) (listed in the regulation as “Myrica cerifera/nagi bark extract”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Katphala?
No single numeric limit is listed in the source for Katphala; permitted use is at GMP or as specified. Confirm against the current regulation.
What product category does Katphala belong to?
Katphala is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Katphala?
Katphala corresponds to Myrica cerifera/nagi, with the bark extract used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.